How paraproteins can affect laboratory assays: spurious results and biological effects
- 1 August 2010
- journal article
- review article
- Published by Elsevier BV in Pathology
- Vol. 42 (5), 397-401
- https://doi.org/10.3109/00313025.2010.493868
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Type III hyperlipoproteinemia with xanthomas and multiple myelomaJournal of the American Academy of Dermatology, 2005
- Acquired myeloma-associated Type III hyperlipidaemia treated by nonmyeloablative HLA-identical sibling allogeneic stem cell transplant using a donor with essential thrombocythaemia (ET): evidence of engraftment without manifestation of ET in recipientBone Marrow Transplantation, 2005
- Paraprotein Interference in Automated Chemistry AnalyzersClinical Chemistry, 2004
- Insulin autoimmune syndrome due to IgG kappa paraproteinPathology, 2004
- Negative Thyrotropin Assay Interference Associated with an IgGκ ParaproteinClinical Chemistry, 2003
- Metastatic multiple myeloma with hyperamylasaemia and hyperlipasaemiaHeart, 1998
- Autoimmune Hyperlipidemia with Inhibitory Monoclonal Antibodies against Low Density Lipoprotein Binding to Fibroblasts in a Case with Multiple Myeloma.Internal Medicine, 1997
- Cutaneous xanthoma in association with paraproteinemia in the absence of hyperlipidemia.JCI Insight, 1989
- Ectopic production of salivary-type amylase by a lga-λ-type multiple myelomaCancer, 1988
- Value of Anion-Gap Determination in Multiple MyelomaThe New England Journal of Medicine, 1977